Format

Send to

Choose Destination
J Clin Virol. 2016 May;78:89-92. doi: 10.1016/j.jcv.2016.03.014. Epub 2016 Mar 16.

Sourcing of the WHO human papillomavirus type 18 international standards for HPV antibody levels.

Author information

1
Department of Laboratory Medicine, Karolinska Institiute, Stockholm, Sweden.
2
National Cancer Institute, Bangkok, Thailand.
3
Department of Laboratory Medicine, Karolinska Institiute, Stockholm, Sweden. Electronic address: Joakim.dillner@ki.se.

Abstract

BACKGROUND:

HPV serology is important for studies of vaccine immunogenicity, but can not be performed in a comparable manner without international standardisation.

OBJECTIVES:

To find suitable candidate sera from naturally infected persons for use as International Standards (IS) for antibodies to high-risk HPVs, with priority for HPV-18.

STUDY DESIGN:

946 healthy Thai women (median age 44, range 18-83) and 61 cervical cancer patients were screened using an HPV pseudovirion-Luminex assay to detect antibodies to genital (HPV-6,-11,-16,-18,-31,-33,-45,-52,-58,-68) and non-genital HPV types (HPV-5,-15,-32,-38 and -76). Suitable candidate sera should ideally be mono-specific (have reactivity against only one genital HPV) and have high antibody levels that are stable over time.

RESULTS:

Seroprevalences of HPV-16,-31,-52 and -58 were at least twice as high among cancer patients compared to healthy individuals. Thirteen healthy women who met the IS inclusion criteria in initial testing also consented to blood-bag donations. Donations from 2 women with high HPV-18 Ab titers were pooled to the HPV-18 candidate IS, later established as the WHO official IS for HPV antibodies. Sera that could potentially be used as candidate IS for other oncogenic HPVs have also been identified.

CONCLUSIONS:

In the Thai population, seroepidemiology implicated HPV types HPV-16,-31,-52 and -58 as particularly associated with cervical cancer. A well characterized cohort study has allowed sourcing of materials for an IS for HPV-18 antibodies and could conceivably be used for IS for other HPV types as well.

KEYWORDS:

Cervical cancer; Human papillomavirus (HPV); International standard serum; Luminex; Serology; Thailand

PMID:
27002710
DOI:
10.1016/j.jcv.2016.03.014
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center